ACAN
-
Official Full Name
aggrecan
-
Overview
This gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene. [provided by RefSeq, Jul 2008] -
Synonyms
ACAN; aggrecan; AGC1; SEDK; AGCAN; CSPG1; MSK16; CSPGCP; aggrecan core protein; large aggregating proteoglycan; cartilage-specific proteoglycan core protein; chondroitin sulfate proteoglycan core protein 1;
- Recombinant Proteins
- Cell & Tissue Lysates
- Protein Pre-coupled Magnetic Beads
- Cattle
- Chicken
- Human
- Mouse
- Rat
- E.coli
- E.Coli or Yeast
- HEK293
- In Vitro Cell Free System
- Mammalian Cell
- Mammalian cells
- Wheat Germ
- C
- His
- GST
- His (Fc)
- Avi
- His|S
- His|T7
- N/A
- N
- Involved Pathway
- Protein Function
- Interacting Protein
- ACAN Related Articles
- ACAN Related Research Area
ACAN involved in several pathways and played different roles in them. We selected most pathways ACAN participated on our site, such as Defective B4GALT1 causes B4GALT1-CDG (CDG-2d), Defective CHST6 causes MCDC1, Defective ST3GAL3 causes MCT12 and EIEE15, which may be useful for your reference. Also, other proteins which involved in the same pathway with ACAN were listed below. Creative BioMart supplied nearly all the proteins listed, you can search them on our site.
Pathway Name | Pathway Related Protein |
---|---|
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | ACAN;FMOD;PRELP;KERA;OGN |
Defective CHST6 causes MCDC1 | OGN;FMOD;ACAN;PRELP;KERA |
Defective ST3GAL3 causes MCT12 and EIEE15 | OGN;KERA;ACAN;PRELP;FMOD |
Degradation of the extracellular matrix | MMP13;CAPNS1;CTSLL;ADAM8A;MMP12;TLDC2;LOC100686744;TIMP2B;CTSL2 |
Disease | TLR10;PDCD6IP;DOCK2;HMGA1;CCDC59;NMT1;ELL;AP1S1;OPN1LW |
Diseases associated with glycosaminoglycan metabolism | PRELP;KERA;OGN;FMOD;ACAN |
Diseases of glycosylation | PRELP;KERA;OGN;ACAN;FMOD |
ECM proteoglycans | COMP;MATN1;ACAN;PTPRS;ITGB3A;COL9A3;BGNB;MATN3B;SPARC |
ACAN has several biochemical functions, for example, carbohydrate binding, extracellular matrix structural constituent, hyaluronic acid binding. Some of the functions are cooperated with other proteins, some of the functions could acted by ACAN itself. We selected most functions ACAN had, and list some proteins which have the same functions with ACAN. You can find most of the proteins on our site.
Function | Related Protein |
---|---|
carbohydrate binding | MBL1;ACAN;CD209B;GRIFIN;CD34;GFPT1;Pla2r1;DGCR2;PYGB |
extracellular matrix structural constituent | LUM;COMP;TINAGL1;COL5A3B;CHI3L1;COL4A4;COL27A1B;LAMA4;MATN1 |
hyaluronic acid binding | BCAN;HAPLN2;VCANB;ACAN;HAPLN3;HAPLN1;TNFAIP6;HAPLN1A;KIAA1199 |
metal ion binding | NT5DC1;EXTL3;GTF2E1;ZNF547;ZFP593;NOS2B;ZNF786;SMYD4;PAPD7 |
protein binding | MYO10;POLD1;MRPL45;SERPINB5;PDCL;BEND5;EZR;SOCS1;TEN1 |
ACAN has direct interactions with proteins and molecules. Those interactions were detected by several methods such as yeast two hybrid, co-IP, pull-down and so on. We selected proteins and molecules interacted with ACAN here. Most of them are supplied by our site. Hope this information will be useful for your research of ACAN.
PCOLCE
- Q&As
- Reviews
Q&As (10)
Ask a questionOne major challenge is the complex nature of the disease, which involves multiple factors and pathways. Additionally, the high heterogeneity of cartilage tissue and the difficulty in obtaining samples pose challenges for experimental studies. Another challenge is the limited understanding of the molecular mechanisms underlying the degradation and synthesis of ACAN protein and its interactions with other matrix molecules and cell surface receptors.
A high purity level of recombinant protein is desirable as it ensures the protein's integrity and reduces the risk of impurities or contaminants that may affect its function.
ACAN protein is a major component of the extracellular matrix of cartilage and plays a critical role in maintaining its structural integrity. ACAN protein helps to maintain the hydration and swelling properties of cartilage by binding to water molecules through its GAG chains. It also interacts with other matrix molecules and cell surface receptors, which contributes to the mechanical properties of cartilage.
ACAN protein is a large proteoglycan consisting of a core protein and long chains of glycosaminoglycans (GAGs), primarily chondroitin sulfate and keratan sulfate. The core protein is composed of several domains, including a signal peptide, a globular domain, and multiple tandem repeats of a hyaluronan-binding domain (HABD).
The purity level of recombinant protein is typically determined through a combination of different techniques, such as SDS-PAGE, HPLC, and mass spectrometry. The purity level of the protein can vary depending on the production method and the quality control measures in place.
Recombinant ACAN protein is suitable for a variety of applications, including biochemical assays, biophysical studies, and structural biology. The protein can also be used in cell culture experiments and in vitro assays to study its interaction with other proteins and molecules. Additionally, recombinant ACAN protein may have potential applications in tissue engineering and regenerative medicine, where it can be used to create biomaterials for cartilage repair and regeneration.
The endotoxin level of recombinant protein is typically tested using the Limulus amebocyte lysate (LAL) assay. Endotoxins are a type of bacterial cell wall component that can contaminate protein samples, and their presence can affect the function of the protein. A low endotoxin level is desirable for recombinant ACAN protein as it ensures the protein's purity and reduces the risk of contamination. You can select specific recombinant protein endotoxin levels in the inquiry form.
The recommended concentration of recombinant ACAN protein for use in cell culture experiments may vary depending on the specific experimental conditions and cell type used. Typically, a concentration range of 10-100 μg/mL is used.
One potential therapeutic strategy is to use molecules that inhibit the degradation of ACAN protein, such as aggrecanase inhibitors. Another approach is to enhance the synthesis of ACAN protein or its GAG chains, which could be achieved by gene therapy or the use of growth factors. Additionally, tissue engineering approaches that aim to regenerate cartilage by using ACAN protein and other matrix molecules have also been explored.
During the development of osteoarthritis, ACAN protein is degraded by various enzymes, including matrix metalloproteinases and aggrecanases. This degradation results in a loss of cartilage integrity, decreased hydration and swelling properties, and altered mechanical properties of cartilage, which contribute to the development of osteoarthritis.
Customer Reviews (3)
Write a reviewThe technical support team at Creative BioMart went above and beyond to customize the ACAN protein to my specific requirements. Their expertise and professionalism were greatly appreciated.
I was thrilled to find the recombinant ACAN protein on sale at such an affordable price.
I highly recommend Creative BioMart to anyone in need of recombinant proteins. Their products are top-notch and their customer service is exceptional.
Ask a Question for All ACAN Products
Required fields are marked with *
My Review for All ACAN Products
Required fields are marked with *